These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8901858)
1. Acute tumor pain in patients with head and neck cancer treated with vinorelbine. Kornek GV; Kornfehl H; Hejna M; Raderer M; Zöchbauer S; Scheithauer W J Natl Cancer Inst; 1996 Nov; 88(21):1593. PubMed ID: 8901858 [No Abstract] [Full Text] [Related]
2. [Acute pain due to vinorelbine]. Cabrera Rodríguez J; Muñoz García J Rev Clin Esp; 1998 Aug; 198(8):514-6. PubMed ID: 9774881 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma. Segura A; Pastor M; Santaballa A; Yuste A; López P; Aparicio J Oncologist; 2000; 5(2):177-8. PubMed ID: 10794811 [No Abstract] [Full Text] [Related]
4. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck. Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N Am J Clin Oncol; 1995 Aug; 18(4):293-6. PubMed ID: 7625368 [TBL] [Abstract][Full Text] [Related]
6. Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients? De Marco S; Fabi A; Ceribelli A; Carlini P; Pollera CF; Cognetti F Ann Oncol; 1999 Jul; 10(7):865-6. PubMed ID: 10470437 [No Abstract] [Full Text] [Related]
7. Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer. Sarkar SK; Patra NB; Goswami J; Basu S J Laryngol Otol; 2008 Feb; 122(2):188-92. PubMed ID: 17445333 [TBL] [Abstract][Full Text] [Related]
8. Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Kornek V; Scheithauer W; Glaser C; Toth J; Duman M; Formanek M; Hejna M; Kornfehl J Oncology; 1999; 56(1):24-7. PubMed ID: 9885373 [TBL] [Abstract][Full Text] [Related]
9. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237 [TBL] [Abstract][Full Text] [Related]
10. Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations. Budman DR; Weiselberg L; O'Mara V J Natl Cancer Inst; 1997 Jan; 89(1):87-8. PubMed ID: 8978412 [No Abstract] [Full Text] [Related]
11. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953 [TBL] [Abstract][Full Text] [Related]
12. Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel. Scalone S; Sorio R; Bortolussi R; Lombardi D; La Mura N; Veronesi A Acta Oncol; 2004; 43(2):209-11. PubMed ID: 15163172 [No Abstract] [Full Text] [Related]
13. [Acute pain at tumor recurrence site induced by vinorelbine infusion]. Shibahara H; Hiramatsu Y Kyobu Geka; 2013 Jul; 66(7):567-9. PubMed ID: 23917136 [TBL] [Abstract][Full Text] [Related]
14. [Induction chemotherapy (cisplatin + vinorelbine) is found to be markedly effective for squamous cell lung carcinoma with sarcoidosis--a case report]. Ohno S; Takemasa A; Kawaguchi K; Teruuchi S; Saitoh N; Hasegawa T; Yamaguchi T; Sohara Y; Hironaka M; Sugiyama Y Gan To Kagaku Ryoho; 2001 Feb; 28(2):235-8. PubMed ID: 11242653 [TBL] [Abstract][Full Text] [Related]
15. Oral vinorelbine may not induce acute pain at the tumor site. Tralongo P; Di Mari A; Agueli R; Gebbia V J Pain Symptom Manage; 2006 Sep; 32(3):197-9. PubMed ID: 16939839 [No Abstract] [Full Text] [Related]
16. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M; Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943 [TBL] [Abstract][Full Text] [Related]
17. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines. Erjala K; Raitanen M; Kulmala J; Grénman R J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904 [TBL] [Abstract][Full Text] [Related]
18. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma]. Bartsch V Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241 [TBL] [Abstract][Full Text] [Related]
19. Intestinal side-effects of docetaxel/vinorelbine combination. de Matteis A; Nuzzo F; Rossi E; Landi G; Perrone F Lancet; 2000 Mar; 355(9209):1098-9. PubMed ID: 10744113 [No Abstract] [Full Text] [Related]
20. A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Wilkowski R; Pachmann S; Schymura B; Dellian M; Schalhorn A; Dühmke E Onkologie; 2005 Oct; 28(10):491-5. PubMed ID: 16160398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]